PH11295A - Method of producing hypolipidemic activity - Google Patents

Method of producing hypolipidemic activity

Info

Publication number
PH11295A
PH11295A PH17786A PH17786A PH11295A PH 11295 A PH11295 A PH 11295A PH 17786 A PH17786 A PH 17786A PH 17786 A PH17786 A PH 17786A PH 11295 A PH11295 A PH 11295A
Authority
PH
Philippines
Prior art keywords
producing
hypolipidemic activity
hypolipidemic
activity
producing hypolipidemic
Prior art date
Application number
PH17786A
Other languages
English (en)
Inventor
H Saunders
C Lowman
N Ditullio
A Maass
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of PH11295A publication Critical patent/PH11295A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PH17786A 1974-11-27 1975-11-21 Method of producing hypolipidemic activity PH11295A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/527,560 US3969508A (en) 1974-11-27 1974-11-27 Lowering the concentration of plasma triglycerides

Publications (1)

Publication Number Publication Date
PH11295A true PH11295A (en) 1977-11-02

Family

ID=24101958

Family Applications (2)

Application Number Title Priority Date Filing Date
PH17786A PH11295A (en) 1974-11-27 1975-11-21 Method of producing hypolipidemic activity
PH19456A PH12855A (en) 1974-11-27 1977-02-16 Pharmaceutical compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH19456A PH12855A (en) 1974-11-27 1977-02-16 Pharmaceutical compositions

Country Status (10)

Country Link
US (1) US3969508A (US08177716-20120515-C00003.png)
AU (1) AU499316B2 (US08177716-20120515-C00003.png)
BE (1) BE835823A (US08177716-20120515-C00003.png)
DE (1) DE2553101A1 (US08177716-20120515-C00003.png)
FR (1) FR2292470A1 (US08177716-20120515-C00003.png)
GB (1) GB1535203A (US08177716-20120515-C00003.png)
IL (1) IL48518A (US08177716-20120515-C00003.png)
NL (1) NL7513877A (US08177716-20120515-C00003.png)
PH (2) PH11295A (US08177716-20120515-C00003.png)
ZA (1) ZA757439B (US08177716-20120515-C00003.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1569404A (en) * 1977-04-22 1980-06-11 Soc D Etudes Prod Chimique (2-isopropyl-4-(2'-theonyl)-5-methyl) phenoxy acetic acid
US4089970A (en) * 1977-09-07 1978-05-16 Smithkline Corporation Method of inhibiting platelet aggregation
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB760114A (en) * 1953-06-19 1956-10-31 Chimie Atomistique Improvements in and relating to compositions for lowering the cholesterol level in the blood serum
US3402198A (en) * 1965-10-20 1968-09-17 William A. Bolhofer 2-(phenoxy), 2-(phenylthio) and 2-(anilino) substituted 2-alkylideneacetic acid derivatives
GB1228236A (US08177716-20120515-C00003.png) * 1968-05-20 1971-04-15
BE757001A (fr) * 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation

Also Published As

Publication number Publication date
ZA757439B (en) 1976-11-24
BE835823A (fr) 1976-05-21
US3969508A (en) 1976-07-13
AU499316B2 (en) 1979-04-12
PH12855A (en) 1979-09-12
IL48518A0 (en) 1976-01-30
FR2292470B1 (US08177716-20120515-C00003.png) 1978-11-10
AU8689475A (en) 1977-06-02
DE2553101A1 (de) 1976-08-12
IL48518A (en) 1978-08-31
GB1535203A (en) 1978-12-13
NL7513877A (nl) 1976-05-31
FR2292470A1 (fr) 1976-06-25

Similar Documents

Publication Publication Date Title
JPS53101385A (en) Method of producing phenyllpyrimidine
CS188985B2 (en) Method of producing aryl-1-azolylmethanes
CS191960B2 (en) Method of producing novel 2-decarboxy-2-/5-tatrazolyl/-11-deoxy-omega-pentanorprostaglandins
JPS51125767A (en) Method of producing food
CS188221B2 (en) Method of producing new 2-tetrahydrofurfuryl-6,7-benzomorphanes
BG24812A3 (en) Method of obtaining 8-thiomethylergolins
CS189715B2 (en) Method of producing aldehydes
ZA75496B (en) Method of producing 1-n-<l-(-)-alpha-hydroxy-epsilon-aminobutyryl> xk-62-2
CS187318B2 (en) Method of producing acylureidocephalosporin compounds
CS188235B2 (en) Method of producing new derivatives ryfamicine
CS191882B2 (en) Method of preparing 7-methoxy-6-thia-tetracycline
CS191264B2 (en) Method of producing new pyridobenzodiazepinones
CS188938B2 (en) Method of producing xanthene-9-spiro-4-piperidines
SU677666A3 (en) Method of producing 7l-or extradiols
CS183850B2 (en) Method of producing 5-fluor-2-methyl-1-/p-methyl-sulphinylbenzyliden/-3-indenylacetic acid
CS189635B2 (en) Method of producing bromderivatives of 4-imido-thioazetidin-2-one
CS182298B2 (en) Method of producing substituted benzendisulphon-amides
CS183785B2 (en) Method of producing s-triazolo-3,4-benzothiazoles
CS194745B2 (en) Method of producing enones
PH11295A (en) Method of producing hypolipidemic activity
CS181287B2 (en) Method of producing n,n-diallyldichloroacetamide
CS179686B1 (en) Method of producing basic phenylethers
CS188945B2 (en) Method of producing 1-aryluracils
CS182294B2 (en) Method of producing new pharmacolagic corticoides
ZA757225B (en) Method of producing energy